logo
Leading Proxy Advisory Firm Backs Simpson Oil's Call for Board Overhaul at Parkland

Leading Proxy Advisory Firm Backs Simpson Oil's Call for Board Overhaul at Parkland

Business Wire29-04-2025
GRAND CAYMAN, Cayman Islands--(BUSINESS WIRE)--Simpson Oil Limited ('Simpson Oil', 'we' or 'our'), the largest shareholder of Parkland Corporation ('Parkland' or the 'Company'), holding 19.8% of the outstanding common shares, today announced that Glass, Lewis & Co. ('Glass Lewis'), a leading independent proxy advisory firm, has recommended that Parkland shareholders support meaningful boardroom change by voting for seven of its nine director nominees at the Company's Annual General Meeting (the 'Meeting' or the 'AGM') to be held on May 6, 2025.
Glass Lewis recommends that shareholders vote the GOLD proxy card to elect Monty Baker, Michael Christiansen, Mark Davis, Chris Folan, Brian Gibson, Darcy Morris, and Karen Stuckey to the Board of Directors (the 'Board').
Simpson Oil reiterates that wholesale change is required, and that only the election of ALL NINE of its highly qualified nominees will deliver the fresh leadership, governance, and accountability shareholders deserve. A clean break is needed from legacy directors like Michael Jennings—whose tenure as Board Chair has been marked by entrenchment, gamesmanship, and value destruction—and James Neate, whose skillsets are neither additive nor needed on a refreshed Board.
In its full report, Glass Lewis affirmed Simpson Oil's case for change, highlighting the magnitude and persistence of the Company's underperformance 1:
' This persistent underperformance, coupled with repeated financial and strategic execution challenges over multiple years, signals that stronger independent board oversight is necessary to drive shareholder value creation and strategic discipline.'
Beyond poor performance, Glass Lewis flagged serious governance concerns, pointing to a pattern of Board 'entrenchment' and 'gamesmanship':
'Taken individually, each of these decisions—from the accelerated 2024 AGM timing, to the decision to include Dissident Nominees on its slate without prior notice or engagement, to the lack of a universal proxy form—could be explained as defensible in isolation. Taken together, however, they reveal a consistent pattern, in our view: the board has repeatedly taken governance actions that appear more reactive than proactive, and more focused on retaining control than facilitating transparent, shareholder-focused outcomes. '
Importantly, Glass Lewis also criticized the incumbent Board's disregard for shareholder input, particularly its past unwillingness to consider strategic alternatives despite persistent underperformance. While the incumbent Board has now reactively launched a strategic review and the CEO has tendered his resignation, Glass Lewis notes:
'With a CEO succession process and strategic alternatives review now running concurrently, it is essential that the board overseeing both be viewed by shareholders and the market as credibly independent, compositionally balanced, and strategically focused. Against this backdrop, we believe that a majority refresh is necessary to realign board composition with shareholder expectations and to ensure credible, shareholder-focused oversight of these critical processes.'
Simpson Oil reaffirms that its nine-person slate is committed to pursuing a dual track process: conducting a comprehensive strategic review while simultaneously repositioning the Company for long-term success—all aligned to the goal of maximizing value for all shareholders.
We are pleased that Glass Lewis, a respected and independent advisory firm, has recognized the consistent pattern of poor governance and ineffective leadership at Parkland, and has concluded that significant boardroom change is needed.
Protect Your Investment: Vote For All NINE Simpson Oil Nominees
For more information on the Simpson Oil nominees, their plan to unlock shareholder value at Parkland, and how to vote for the entire Simpson Oil slate on the GOLD Proxy Card, visit www.RefuelParkland.com. Proxy materials are also available under Parkland's SEDAR+ profile at www.sedarplus.ca, including a GOLD Proxy Card or voting instruction form. The deadline to return proxies to Simpson Oil is 5:00 p.m. (Calgary time) on Thursday, May 1, 2025.
If you would like to vote shares that you hold in your Employee Share Purchase Plan (ESPP), if you have not received your Voting Instruction Form (VIF) by mail, or if you need help voting the GOLD proxy, please contact Carson Proxy, at 1-800-530-5189 (North America Toll Free), 416-751-2066 (Local and Text), or by email at info@carsonproxy.com.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Wealth tax for school funding initiative starts signature collection with opposition pouncing
Wealth tax for school funding initiative starts signature collection with opposition pouncing

Yahoo

timean hour ago

  • Yahoo

Wealth tax for school funding initiative starts signature collection with opposition pouncing

A copy of the petition to be circulated by the Invest in MI Kids Ballot Proposal Coalition. July 31, 2025 | Photo By Kyle Davidson/Michigan Advance The constitutional amendment to implement a new tax on wealthy Michiganders is still aiming for the 2026 ballot after facing some initial setbacks and new attacks, with its signature collection driving kicking off on Friday. Members of Invest in MI Kids said it started collecting signatures last week using the 100-word summary that was approved June 27 by the Michigan Board of State Canvassers. That has opened up further complications for the effort, as the board on July 10 walked back the approval for the previous 100-word summary and then deadlocked on a revised summary at their July 31 meeting. Initiative officials said Friday that the effort which resulted in the board deadlocking was just one part of well-funded right-wing attacks against the proposal, which is estimated to generate nearly $1 billion annually. But those attacks keep coming. The Coalition to Stop the Business and Family Tax Hike, an organization opposed to the Invest in MI Kids initiative, issued a cease and desist motion to prevent the group from collecting its signatures. Jase Bolger, CEO of West Michigan Policy Forum and a former Republican Michigan House speaker, said in a statement that the amendment would hurt small businesses – even though the initiative was aimed at the wealthiest Michiganders. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX 'I applaud the move today by the Coalition to Stop the Business and Family Tax Hike,' Bolger said. 'They filed a cease and desist motion to stop the signature gathering for an unapproved ballot initiative. Because, the proponents of this devastating proposal are using language that is misleading. Voters should not be fooled.' In response, Imani Foster, a spokesperson for the Invest MI Kids initiative, told Michigan Advance that the coalition is focused on the task at hand. 'While we're busy engaging Michiganders, together with our thousands of volunteers, we won't be distracted by meaningless letters from big money Washington lawyers,' Foster said. The group also noted its belief that the board had no authority under Michigan law to rescind its prior approval of the petition summary language. 'The petitions currently being circulated by Invest in MI Kids include a petition summary that the director of elections has deemed compliant with the Michigan Election Law twice and that the Board of Canvassers has approved as compliant once,' Foster added. Solve the daily Crossword

ZetaDisplay – CEO Anders Olin steps down, Daniel Nergard, appointed as new CEO
ZetaDisplay – CEO Anders Olin steps down, Daniel Nergard, appointed as new CEO

Yahoo

timean hour ago

  • Yahoo

ZetaDisplay – CEO Anders Olin steps down, Daniel Nergard, appointed as new CEO

ZetaDisplay – CEO Anders Olin steps down, Daniel Nergard, appointed as new CEO. Malmö - ZetaDisplay AB (publ) today announces that Anders Olin will be stepping down from his role as CEO after almost 2 years. During his tenure, Anders Olin has led the company through a period of significant progress – professionalising operations, building unity across the organisation, and laying a solid foundation for future growth. Under his leadership, the company also expanded into a new market through the acquisition of a business in the UK. Rob Woodward, Chair of the Board, says 'We warmly thank Anders Olin for his dedication to duty and his contribution to positioning the company for future growth, and we wish him the very best in his future.' Daniel Nergard is appointed the new CEO of ZetaDisplay, starting on 1st October. Daniel Nergard, is an experienced senior leader who has been working in the global enterprise software segment for 20+ years, with recent experience from live media production with Vizrt Group. Prior to this Daniel led Qmatic's commercial function. His focus has been to lead the development of customer centric product offerings, monetised through strong commercial leadership. Anders Olin will remain available until the new CEO is in place to ensure a smooth transition and a great start for his successor. Malmö, 19th August 2025 This information is information that ZetaDisplay AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of Rob Woodward, at 13:00 CET on 19th August 2025 For further questions, please contact: Rob Woodward, Chair of the board Mobile: +44 7770 311367 E-Mail: Claes Pedersen, CFO Mobile: +45 23-68 86 58 E-Mail: ABOUT ZETADISPLAY More than two decades of leadership and innovation in digital signage. ZetaDisplay was founded 2003 in Sweden as one of the early pioneers of digital signage software and solutions. Today ZetaDisplay is of the leading European corporations in the digital signage market and a leading force in the European and global digital signage industry. Our proprietary software platform, digital business development and consulting services, innovative digital signage solutions, and creative concepts regularly inspire- influence and guide millions of people every day in retail environments, in restaurants, on advertising screens, in factories, on trains, on cruise ships, in stadiums, in workplaces and in all types of public spaces indoor and outdoor. ZetaDisplay is one of the largest leading European digital signage companies with direct operations in eight European countries and the US with +125,000 active installations in over 50 countries, across all major continents where we are the business partner of choice for many of the worlds most respected blue-chip brands and companies. ZetaDisplay is based in Malmö-Sweden, has a turnover of SEK +600 million and employs approx. 250 co-workers. ZetaDisplay is owned by the investment company Hanover Investors. More information about ZetaDisplay can be found on the group global website or for Investor relations at or for owner information at Attachment ZetaDisplay announces new CEO

Coloplast A/S - Announcement no. 05/2025 - Coloplast announces changes to Executive Leadership Team
Coloplast A/S - Announcement no. 05/2025 - Coloplast announces changes to Executive Leadership Team

Yahoo

time5 hours ago

  • Yahoo

Coloplast A/S - Announcement no. 05/2025 - Coloplast announces changes to Executive Leadership Team

Coloplast announces changes to Executive Leadership Team The Coloplast Board of Directors are making changes to the Executive Leadership Team (ELT) to support the successful execution of the new Coloplast Group strategy. Over the last couple of months, senior leaders from across the Coloplast Group have worked together to finalise the new Coloplast Group strategy, which will be communicated internally and externally in early September following approval by the Board of Directors. 'Our new strategy is centered around our customers. We will create and deliver the best customer experience for our users, patients and clinicians across our offering of products, support and services. Our ambition is to set the standard of care, to lead the market and to win!' says Lars Rasmussen, interim CEO of Coloplast. 'To deliver value for our customers, shareholders and more, we must evolve. That means putting the customer at the centre of everything we do. It also means delivering a step change in innovation to solidify our position as the innovation leader in our industry,' says Lars. During the current strategy period, the Coloplast Group has expanded with the addition of Atos Medical and Kerecis. Effective immediately, the company will organise its businesses into two distinct business units: Chronic Care and Acute Care. This structure allows the company to respect the differences in market dynamics, customer needs, patient pathways and business models, and it creates the needed structure to execute on the company's 2030 strategy. Changes to Chronic CareEffective immediately, a new Chronic Care Commercial business unit is being established. This will include the existing Chronic Care sales regions as well as relevant Chronic Care commercial functions. Given the chronic nature of most patients served by Atos Medical, the Voice & Respiratory Care business, Atos will also become part of the new Chronic Care Commercial business unit. To deliver a step change in innovation and bring new products faster to market, a stand-alone Chronic Care R&D function is also being established. 'As we are making significant changes to the Chronic Care setup, the Board and Executive Vice President Nicolai Buhl have mutually agreed that Nicolai will leave Coloplast. Nicolai has achieved great things in his time with Coloplast as a senior leader within Wound Care as well as Chronic Care. On behalf of the Board and the ELT, I want to thank Nicolai for his dedication and leadership,' says Lars. Caroline Vagner Rosenstand will take on the role as Executive Vice President of Chronic Care Commercial. 'Caroline is an experienced leader with a great track record of building followership, defining and executing on commercial strategies and delivering results,' says Lars. On November 1st, Rasmus Just will step into the role of Executive Vice President of Chronic Care R&D. Rasmus Just brings valuable experience from his five years at Coloplast, where he held several leadership roles within innovation, before continuing his career for the past 3 years in Device R&D at Novo Nordisk. 'Rasmus is an experienced R&D leader with a strong technology and business focus, and we are happy to welcome him back to Coloplast,' says Lars. Introducing Acute CareThe new Acute Care business unit includes Interventional Urology (IU), Advanced Wound Dressings (AWD) and Kerecis. These treatment areas are characterised by premium products like Coloplast's penile implants, the Kerecis fish skin portfolio and our wound dressings. Most of these products and technologies are used in specialised private clinics or in the hospital setting, where innovation and clinical outcomes are critical. Effective immediately, the AWD and Kerecis commercial organisations are being merged into a new Wound & Tissue Repair organisation within Acute Care. The goal is to become an innovation leader in this area and to create a strong global footprint by merging these two complementary businesses. Wound & Tissue Repair will be led by Executive Vice President Fertram Sigurjonsson. 'With Kerecis, Fertram has built a company with strong innovation capability and growth potential based on a unique technology. Bringing these capabilities together in a new Wound & Tissue Repair unit represents a significant milestone for our AWD and Kerecis businesses,' says Lars. There are no changes to the IU business, which will continue under the leadership of Executive Vice President Tommy Johns. 'I would like to congratulate Caroline, Fertram and Rasmus on their new roles,' ends Lars. The new ELT Lars Rasmussen, interim CEO Anders Lonning-Skovgaard, EVP & CFO Allan Rasmussen, EVP Global Operations Dorthe Rønnau, EVP People & Culture Caroline Vagner Rosenstand, EVP Chronic Care Commercial Rasmus Just, EVP Chronic Care R&D (start date 1 November) Fertram Sigurjonsson, EVP Wound & Tissue Repair Tommy Johns, EVP Interventional Urology Lars Rasmussen, interim President and CEO, and Anders Lonning-Skovgaard, Executive Vice President and CFO, constitute the management registered with the Danish Business Authority. ContactsPeter MønsterSr. Media Relations ManagerTel. +45 4911 2623Email: dkpete@ Aleksandra DimovskaVice President, Investor RelationsTel. +45 4911 2458Email: dkadim@ Kristine Husted MunkSenior Manager, Investor RelationsTel. +45 4911 3266Email: dkkhu@ Simone Dyrby HelvindSenior Manager, Investor RelationsTel. +45 4911 2981Email: dksdk@ This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail. Coloplast was founded on passion, ambition, and commitment. We were born from a nurse's wish to help her sister and the skills of an engineer. Guided by empathy, our mission is to make life easier for people with intimate healthcare needs. Over decades, we have helped millions of people to live a more independent life and we continue to do so through innovative products and services. Globally, our business areas include Ostomy Care, Continence Care, Advanced Wound and Skin Care, Interventional Urology and Voice and Respiratory Care. The Coloplast logo is a registered trademark of Coloplast A/S. © 2025-08. All rights reserved Coloplast A/S, 3050 Humlebaek, 05_2025_Coloplast_announces_changes_to_ELTSign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store